# Cost Effectiveness of Midostaurin in the Treatment of Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia in the United States

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cost-effectiveness-of-midostaurin-in-the-treatment-of-newly-diagnosed-flt3/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Eytan M. Stein,Jipan Xie,Emilie D. Duchesneau,S. Bhattacharyya,Umakanth Vudumula,Briana Ndife,Gaetano Bonifacio,Annie Guérin,Nanxin Li,George Joseph |
| Citations | 14 |
| DOI | 10.1007/s40273-018-0732-4 |
| Fields | Medicine,Social Sciences |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2899466366 |
| PMID | 30382485 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Briana Ndife](https://scholariq.org/researchers/briana-ndife/)

## Paper journal

- [PharmacoEconomics](https://scholariq.org/journals/pharmacoeconomics/)

## Paper primary topic

- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)

## Paper topics

- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.